Clinical trials
Coronary Artery Disease trials in Egypt
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 5 |
| 2023 | 8 |
| 2024 | 5 |
| 2025 | 7 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Unknown status | 14 |
| Recruiting | 3 |
| Not yet recruiting | 3 |
| Active, not recruiting | 2 |
| Withdrawn | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 11 |
| Cairo University | 6 |
| Sohag University | 4 |
| Ain Shams University | 3 |
| Damanhour University | 3 |
| Alexandria University | 2 |
| Helwan University | 2 |
| Mansoura University | 2 |
| Terumo Europe N.V. | 2 |
| The Young Investigator Group of Cardiovascular Research | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 50 |
| Acute Coronary Syndrome | 4 |
| Diabetes Mellitus, Type 2 | 3 |
| Myocardial Infarction | 3 |
| ST Elevation Myocardial Infarction | 3 |
| Heart Valve Diseases | 2 |
| Premature Birth | 2 |
| Acute Pain | 1 |
| Aortic Valve Disease | 1 |
| Cardiovascular Diseases | 1 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.